Search Results 1291-1300 of 18652 for Appendix

1. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

   Congenital long QT syndrome or concomitant medications known to prolong the QT interval as defined in Appendix F;; A marked baseline prolongation of QT/QTc ...

2. Small bowel cancer - Doctors and departments - Mayo Clinic

   ... Appendix cancer, Liver cyst, Bile duct cyst, Bile duct injury, Duodenal cancer, Liver tumor, Liver hemangioma, Liver metastasis. Show more areas of focus for ...

3. Small bowel cancer - Doctors and departments - Mayo Clinic

   Young-onset rectal cancer, Appendix cancer. Show more areas of focus for Katrina S. Pedersen, M.D.. Ken M. Porche, M.D., M.A..

4. Pembrolizumab With Chemotherapy and With/Without MK-4830 for Treating Participants With Ovarian Cancer - Mayo Clinic

   Chemotherapy: 180 days (refer to Appendix 7 for country-specific requirements);; Avastin (or biosimilar if administered): 180 days; The investigator should ...

5. Breast cancer - Doctors and departments - Mayo Clinic

   ... Appendix cancer. Show more areas of focus for Sanjay P. Bagaria, M.D.. Saranya Chumsri, M.D.. Oncologist. Jacksonville, FL. Areas of focus ...

6. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   ECOG Performance Status (PS) 0 or 1 (Appendix I). Adequate pulmonary function ascertained by treating surgeon obtained ≤30 days prior to registration. A ...

7. Breast cancer - Doctors and departments - Mayo Clinic

   ... Appendix cancer. Show more areas of focus for Sanjay P. Bagaria, M.D.. Saranya Chumsri, M.D.. Oncologist. Jacksonville, FL. Areas of focus ...

8. Breast cancer - Doctors and departments - Mayo Clinic

   ... Appendix cancer. Show more areas of focus for Sanjay P. Bagaria, M.D.. Saranya Chumsri, M.D.. Oncologist. Jacksonville, FL. Areas of focus ...

9. Ablation therapy - Doctors & Departments - Mayo Clinic

   ... Appendix cancer, Gastrointestinal stromal tumor, Enlarged spleen, Recurrent cancer, Liver metastasis, Duodenal cancer, Bile duct injury, Bile duct cyst ...

10. BT – L-CsA – 301 – SLT: A Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trial To Demonstrate The Efficacy And Safety Of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered Via The PARI Investigational EFlow® Device Plus Standard Of Care Versus Standard Of Care Alone In The Treatment Of Chronic Lung Allograft Syndrome / Bronchiolitis Obliterans Syndrome In Patients Post Single Lung Transplantation - Mayo Clinic

    ... Appendix II of the protocol through their End of Study Visit. Patients have no concomitant diagnoses that are considered fatal within one year (12 months) ...